(Q48159462)

9 February 2018

title

Inactivation gating and 4-AP sensitivity in human brain Kv1.4 potassium channel (English)

1 reference

9 February 2018

author name string

Judge SI

1

1 reference

9 February 2018

Monteiro MJ

2

1 reference

9 February 2018

Yeh JZ

3

1 reference

9 February 2018

Bever CT

4

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 June 1999

1 reference

9 February 2018

published in

Brain Research

1 reference

9 February 2018

volume

831

1 reference

9 February 2018

issue

1-2

1 reference

9 February 2018

page(s)

43-54

1 reference

9 February 2018

Characterization of a mammalian cDNA for an inactivating voltage-sensitive K+ channel

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

The effects of 4‐aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

A family of three mouse potassium channel genes with intronless coding regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Mechanism of 4-aminopyridine action on voltage-gated potassium channels in lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

A new technique for the assay of infectivity of human adenovirus 5 DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Biophysical and molecular mechanisms of Shaker potassium channel inactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Putative receptor for the cytoplasmic inactivation gate in the Shaker K+ channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N141I).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Effects of 4-aminopyridine in patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Gating-dependent mechanism of 4-aminopyridine block in two related potassium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Segmental exchanges define 4-aminopyridine binding and the inner mouth of K+ pores

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Modulation of aminopyridine block of potassium currents in squid axon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

A mammalian transient type K+ channel, rat Kv1.4, has two potential domains that could produce rapid inactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Treatment of Lambert-Eaton syndrome: 3,4-diaminopyridine and pyridostigmine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Alternative splicing contributes to K+ channel diversity in the mammalian central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

A role for hydrophobic residues in the voltage-dependent gating of Shaker K+ channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Physiology and pharmacology of epileptiform activity induced by 4-aminopyridine in rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Bi-stable block by 4-aminopyridine of a transient K+ channel (Kv1.4) cloned from ferret ventricle and expressed in Xenopus oocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Inactivation properties of voltage-gated K+ channels altered by presence of beta-subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Molecular biology of the voltage-gated potassium channels of the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Cloning of a human cDNA expressing a high voltage-activating, TEA-sensitive, type-A K+ channel which maps to chromosome 1 band p21

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Cloning and functional expression of a TEA-sensitive A-type potassium channel from rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Subcellular segregation of two A-type K+ channel proteins in rat central neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Mutational analysis of ion conduction and drug binding sites in the inner mouth of voltage-gated K+ channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Role of transmembrane segment S5 on gating of voltage-dependent K+ channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

The S4-S5 loop contributes to the ion-selective pore of potassium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

4-Aminopyridine improves clinical signs in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

On the mechanism of 4-aminopyridine action on the cloned mouse brain potassium channel mKv1.1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

4-Aminopyridine leads to restoration of conduction in demyelinated rat sciatic nerve.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Aminopyridines and synaptic transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Aminopyridine block of transient potassium current

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Functional role of the NH2-terminal cytoplasmic domain of a mammalian A-type K channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Alteration and restoration of K+ channel function by deletions at the N- and C-termini.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Aminopyridines block an inactivating potassium current having slow recovery kinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Aminopyridines and the treatment of spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Modulation of 4-AP block of a mammalian A-type K channel clone by channel gating and membrane voltage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Dynamics of aminopyridine block of potassium channels in squid axon membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Potassium channels from NG108-15 neuroblastoma-glioma hybrid cells. Primary structure and functional expression from cDNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Restoration of inactivation in mutants of Shaker potassium channels by a peptide derived from ShB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

Molecular basis of K+ channel inactivation gating.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901391-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(99)01391-8

1 reference

9 February 2018

1 reference

9 February 2018